Hycanthone: an alkylating agent [proceeding
Miller, J.L.; Hulbert, P.B.
Journal of Pharmacy and Pharmacology 28 Suppl: 18p
1976
ISSN/ISBN: 0022-3573 PMID: 12291 Document Number: 97042
Document emailed within 1 workday
Related Documents
Tura, S.; Mazza, P.; Gherlinzoni, F.; Zinzani, P.L.; Poletti, G.; Visani, G.; Lemoli, R.M.; Bandini, G.; Cavo, M.; Galieni, P. 1988: Phase Ii study with a new alkylating agent (PTT-119) in lymphoid malignancies Haematologica 73(6): 503-508Iamshchikov, N.V. 1981: Ultrastructural analysis of reactive changes in the myocardium upon embryo exposure to an alkylating agent Arkhiv Anatomii Gistologii i Embriologii 80(3): 64-68
Kotova, D.G.; Zel'dovich, D.R.; Maliugina, L.L. 1975: Use of an alkylating agent from the symm. triazine group on malignant tumors of the ovaries Voprosy Onkologii 21(3): 100-101
Russo, J.E.; Hilton, J.; Colvin, O.M. 1989: The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide Progress in Clinical and Biological Research 290: 65-79
Ecknauer, R. 1976: Morphology and enzyme aktivity in rat small intestinal epithelium 6 and 12 hrs. after an alkylating agent (cyclophosphamide) Acta Hepato-Gastroenterologica 23(5): 365-371
Gardella, S.; Cervantes, F.; Bladé, J.; Brugués, R.; Rozman, C. 1982: Acute myeloproliferative syndrome after alkylating agent treatment in a case of multiple myeloma Medicina Clinica 79(4): 185-188
Lemoli, R.M.; Visani, G.; Tosi, P.; Mazza, P.; Motta, M.R.; Rizzi, S.; Zinzani, P.L.; Poluzzi, C.; Gherlinzoni, F.; Tura, S. 1988: Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM) Haematologica 73(3): 195-200
Tobey, R.A.; Tesmer, J.G. 1985: Differential response of cultured human normal and tumor cells to trace element-induced resistance to the alkylating agent melphalan Cancer Research 45(6): 2567-2571
Pogrebniak, A.; Schemainda, I.; Pelka-Fleischer, R.; Nüssler, V.; Hasmann, M. 2003: Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects European Journal of Medical Research 8(10): 438-450
Bhuyan, B.K.; Smith, K.S.; Kelly, R.C.; Adams, E.G.; Abraham, I.; Sampson, K.E. 1993: Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin Cancer Research 53(6): 1354-1359
Wang, Y.Y.; Teicher, B.A.; Shea, T.C.; Holden, S.A.; Rosbe, K.W.; al-Achi, A.; Henner, W.D. 1989: Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance Cancer Research 49(22): 6185-6192
Dewes, H.; Racenberg, E. 1970: Comparison of different proceeding of oxygen therapy Cahiers d'Anesthesiologie 18(2): 155-163
Millership, J.S.; O'Hare, R.E. 1976: Trimethylsilylethers of enthinylalcohols as latentiated drugs [proceeding Journal of Pharmacy and Pharmacology 28 Suppl: 14p
Wortmann, F. 1976: Specific hyposensitization: indications and practical proceeding Schweizerische Rundschau für Medizin Praxis 65(5): 125-126
Ferraz, M.P.; Borges, D.R.; Vilela, M.P.; Braziliano, C.J. 1973: Symptomatic psychosis after the use of hycanthone Revista Paulista de Medicina 81(5): 275-278
Maritz, J.C. 1970: Hycanthone therapy in bilharziasis South African Medical Journal 44(5): 126-128
Green, S.; Sauro, F.M.; Legator, M.S. 1973: Cytogenetic effects of hycanthone in the rat Mutation Research 17(2): 239-244
Makarov, I.A.; Solov'eva, M.S.; Frigo, N.V.; Makarenko, K.I. 1981: Hypophyseal-adrenal system function in normally proceeding pregnancy Akusherstvo i Ginekologiia 5: 30-31
Olsen, J.R.; Michalski, J.M. 2013: PSA screening for colorectal cancer patients: proceeding with caution Oncology 27(10): 1041-1042
Dennis, E.W.; Kobus, W. 1974: A review of the clinical pharmacology of hycanthone Egyptian Journal of Bilharziasis 1(1): 35-53